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A New Dexamethasone-Induced Gene
of the Leucine Zipper Family Protects
T Lymphocytes from TCR/CD3-Activated Cell Death
Engagement of the TCR/CD3 complex, (either by anti-
gen-presenting cells [APCs] presenting antigenic pep-
tide or by anti-CD3 antibody), cytokines, coaccessory
molecules, and tissue microenvironment triggers a se-
ries of activation events, which can contribute to regu-
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late cell survival (Nieto and Lopez-Rivas, 1989; Nieto etSection of Pharmacology
al., 1990; Migliorati et al., 1993; Boise et al., 1995; AkbarDepartment of Clinical Medicine, Pathology
and Salmon, 1997; Ayroldi et al., 1997). Elevation ofand Pharmacology
intracellular Ca21, protein phosphorylation/dephosphor-University of Perugia
ylation, up-regulation of the antioxidant glutathione, ex-Via del Giochetto
pression of Bcl-2/Bcl-x and of the Fas/Fas ligand (Fas/06100 Perugia
FasL) systems, and activation of transcription factors,Italy
such as NF-kB, Myc, Fos, and Jun, profoundly influ-
ence T cell apoptosis (Itoh et al., 1991; Shi et al., 1992;
Smeyne et al., 1993; Veis et al., 1993; Goldstone and
Lavin, 1994; Alderson et al., 1995; Dhein et al., 1995; JuSummary
et al., 1995; Beg and Baltimore, 1996). Some of these
signals can induce apoptosis in thymocytes, mature TBy comparing mRNA species expressed in dexa-
cells, and T cell hybridomas (Webb et al., 1990). In partic-methasone (DEX)±treated and untreated murine thy-
ular, activation of T cell hybridomas leads to cell cyclemocytes, we have identified a gene, glucocorticoid-
arrest, followed by apoptosis. This activation-inducedinduced leucine zipper (GILZ), encoding a new member
cell death (AICD) (Kabelitz et al., 1993) requires the inter-of the leucine zipper family. GILZ was found expressed
action of Fas with FasL (Alderson et al., 1995; Dhein etin normal lymphocytes from thymus, spleen, and
al., 1995; Ju et al., 1995).lymph nodes, whereas low or no expression was de-
Amongdifferent stimuli, glucocorticoid hormones (GCH)tected in other nonlymphoid tissues, including brain,
are also critical regulators of T cell development (Wyllie,kidney, and liver. In thymocytes and peripheral T cells,
1980; Cohen and Duke, 1984). In particular, dexametha-GILZ gene expression is induced by DEX. Furthermore,
sone (DEX), a synthetic GCH, which by itself inducesGILZ expression selectively protects T cells from apo-
apoptosis in T cell hybridomas and in normal T lympho-ptosis induced by treatment with anti-CD3 monoclonal
cytes, can inhibit AICD induced by triggering of the TCR/antibody but not by treatment with other apoptotic
CD3 complex (Zacharchuk et al., 1990). This inhibitionstimuli. This antiapoptotic effect correlates with inhibi-
may be due to a number of events, including preventiontion of Fas and Fas ligand expression. Thus, GILZ is
of activation-induced expression of FasL (Yang et al.,a candidate transcription factor involved in the regula-
1995a, 1995b).tion of apoptosis of T cells.
To study the role of GCH in the regulation of lympho-
cyte apoptosis, we attempted the isolation of genes that
Introduction are induced by DEX and modulate apoptosis in T cells.
We report here the identification of a gene, glucocorti-
Apoptosis (programmed cell death [PCD]) is involved in coid-induced leucine zipper (GILZ), coding for a novel
cell and tissue development as well as in the control of member of the leucine zipper family. Our results indicate
neoplastic growth (Kerr et al., 1972; Wyllie et al., 1980; that GILZ gene is induced in thymocytes and peripheral
Bursch et al., 1992; Cohen, 1993; Osborne and Schwartz, T cells by DEX. Furthermore, we show that GILZ expres-
1994). A number of stimuli can either induce or inhibit sion selectively protects T cells from apoptosis induced
lymphocyte PCD through activation of molecules acting by treatment with anti-CD3 monoclonal antibody (MAb)
at different levels, including the cell membrane, cyto- but not by treatment with other apoptotic stimuli, and
plasm, and nucleus. The definition of the signaling we show that this inhibition correlates with inhibition of
pathways involved in the control of apoptosis has impor- anti-CD3±induced up-regulation of Fas and FasL ex-
tant implications for the understanding of normal tissue pression.
development and drug resistance.
In the T cell lineage, several pathways have been Results
identified that regulate apoptosis negatively or positively
(Dent et al., 1990; MacDonald and Lees, 1990). In par- Isolation of the GILZ cDNA
As part of a research program aimed at studying theticular, apoptosis activated through the antigen inter-
role of glucocorticoid hormones in the regulation ofaction with the T cell receptor (TCR)/CD3 complex is
lymphocyte apoptosis, we attempted the isolationresponsible for negative selection (Jenkinson et al.,
of mRNA species induced by three hours of treatment1989; Smith et al., 1989).
with the synthetic glucocorticoid hormone DEX (100 nM)
in freshly isolated thymocytes.
Comparing the cDNAs from untreated and DEX-*To whom correspondence should be addressed (e-mail: riccardi@
unipg.it). treated cells by the subtraction probe technique, we
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identified some mRNA species overexpressed in the
treated cells. Upon sequencing various isolated cDNAs,
one of them, GILZ, was shown to have some homology
(67% identity in the coding region) with the mouse TSC-
22, a transforming growth factor b-inducible leucine zip-
per gene (Shibanuma et al., 1992), and no homology
with other sequences present in European Molecular
Biology Laboratory and GenBank databases. This probe
was used to screen a thymus lymphocyte cDNA library
in order to isolate the corresponding full-length cDNA
clone. Several clones were isolated, and three of them
were 1972 bp long and displayed the same sequence.
Since Northern blot analysis (Figure 1) indicated that
GILZ mRNA was about 2 kb long, these clones were
though to represent full-length cDNAs. This was con-
firmed by experiments with primer-extension technique
(data not shown).
GILZ Expression in Tissues: Induction
in T Lymphocytes
We performed experiments to define GILZ expression
in different tissues. Results indicated that GILZ mRNA
was clearly detectable by Northern blot analysis in
freshly isolated thymocytes, spleen, and lymph node
cells; slightly detectable in bone marrow, kidney, and
lung cells; and not detectable in liver, heart, and brain
cells, suggesting that the gene is mainly expressed in
lymphoid tissues (Figure 1A). We then performed experi-
ments to test the possible effect of DEX treatment on
lymphoid tissue. Results indicate that GILZ expression
was clearly increased by treatment with DEX in fresh
thymocytes and lymphocytes from peripheral lymphoid
tissues, including spleen and lymph nodes (Figure 1B).
On the contrary, DEX treatment did not induce detect-
able GILZ expression in liver cells (data not shown).
The Protein Coded by GILZ Is a Leucine
Zipper Protein
Nucleotide sequence of the three cDNA clones showed
the presence of a single base pair open reading frame,
beginning at nucleotide position 206 and extending to
a tumor-associated antigen termination codon at posi-
tion 617. The putative initiation codon at position 206
Figure 1. Northern Blot Analysis of GILZ Expression
is surrounded by a sequence (GAACCATGA), in good
(A) Organ distribution of GILZ mRNA. Total RNA was extracted,agreement with the consensus sequence for initiation of
separated on agarose gel, and transferred to nitrocellulose filter.
translation in eukaryotes (Kozak, 1989). The termination The filter was hybridized with nick translation labeled GILZ cDNA
codon is followed by a 39 untranslated region of 1355 probe, washed, and exposed for autoradiography for 8 days. Each
lane was loaded with 20 mg of total RNA.bp. A polyadenylation signal is present 45 bp 59 to the
(B) Effect of DEX on GILZ induction. Cells were either untreated orpoly (A) tail (Figure 2A).
treated with 100 nM DEX for 3 hr. Total RNA (25 mg) was extracted,The protein encoded putatively by the GILZ mRNA is
run on a gel, and transferred to the filter. The filter was hybridized
a leucine zipper protein of 137 amino acids (aa) (Figure with labeled GILZ cDNA and exposed for autoradiography for 24 hr.
2A) that displays 64% identity with TSC-22 and signifi-
cant homologies with other molecules belonging to the
leucine zipper family (Figure 2B; Hope and Struhl, 1987; 15,165 Da. This molecular weight was confirmed by
in vitro translation experiments performed using theLamph et al., 1988; Yamamoto et al., 1988; Nicholas et
al., 1991; Shibanuma et al., 1992), as confirmed by the cloned cDNA (Figure 3Aa).
A rabbit immune antiserum was used to detect a cellu-presence of four leucine residues at positions 76, 83,
90, and 97 and one asparagine at position 87. Further- lar product of GILZ in normal untreated or DEX-treated
(6 hr treatment) thymocytes. In particular, a band ofmore, a proline and acid aa rich region (PAR) is present
at the 39 end region (double underlined in Figure 2A). molecular mass of approximately 17 kDa was detected
by this antiserum in the protein extract of DEX-treatedThe predicted molecular weight of the putative mature
protein before further posttranslation modifications is thymocytes (Figure 3Ab, lane 4) and, although at a lower
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Figure 3. Analysis of GILZ Protein Expression: Subcellular Local-
ization
(A) Product of GILZ cDNA. (a) In vitro translation. GILZcDNA inserted
Figure 2. GILZ Gene Codes for a Leucine Zipper Protein into Bluescript vector was transcribed, and transcripts were trans-
(A) Nucleotide sequence of GILZ and putative polypeptide sequence lated in a rabbit reticulocyte lysate in the presence of [35S]Met (lane
of GILZ. Open box, the leucine zipper domain; underlining, basic 1, rabbit reticulocyte lysate; lane 2, empty vector; lane 3, vector
residues; double underlining, proline and acidic residues of the PAR with GILZ cDNA). (b) Western blot analysis of GILZ protein was
region. performed by rabbit preimmune serum (lane 1, untreated thymo-
(B) Comparison of the leucine zipper motif in the open reading cDNA cytes; lane 2, thymocytes treated with DEX 100 nM) or rabbit immune
with those of other members of the leucine zipper family. antiserum (lane 3, untreated thymocytes; lane 4, thymocytes treated
with DEX). (c) Protein immunoblot analysis of GILZ protein in
transfected 3DO clones: nucleic proteins extracted from a clone
transfected with the empty vector (lane 1) or with GILZ cDNA (lanelevel, in the protein extract of untreated thymocytes
2); cytoplasm proteins extracted from a clone transfected with the
(Figure 3Ab, lane 3) in a Western blot analysis. A rabbit empty vector (lane 3) or with GILZ cDNA (lane 4). (d) Protein immu-
preimmune serum was used as control with protein ex- noblot analysis of b-tubulin protein in transfected 3DO clones: nu-
tract of untreated (Figure 3Ab, lane 1) or of DEX-treated cleic proteins from an empty vector- (lane 1) or a GILZ-transfected
(lane 2) clone; cytoplasm proteins from an empty vector clone (lanethymocytes (Figure 3Ab, lane 2).
3) or a GILZ-transfected (lane 4) clone.
(B) GILZ induction by anti-CD3 plus DEX treatment. (a) WesternGILZ Expression: Subcellular Localization
blot analysis of GILZ protein (lane 1, untreated thymocytes; lane 2,
We also performed experiments to define the subcellular thymocytes treated for 3 hr on plates coated with anti-CD3 (1 mg/
localization of GILZ. For that purpose we evaluated the ml); lane 3, thymocytes treated with 100 nM DEX for 3 hr; lane 4,
levels of GILZ in the nucleus and the cytoplasm by West- thymocytes treated for 3 hr with anti-CD3 plus DEX. (b) Northern
blot analysis of GILZ mRNA (lane 1, untreated thymocytes; lane 2,ern blot experiments in clones transfected with the
thymocytes treated for 3 hr on plates coated with anti-CD3 (1 mg/empty vector or with the GILZ cDNA. Results of a repre-
ml); lane 3, thymocytes treated with 100 nM DEX for 3 hr; lane 4,sentative experiment (Figures3Ac and 3Ad) showed that
thymocytes treated for 3 hr with anti-CD3 plus DEX. Total RNA (25
GILZ isdetectable in the nucleusof theGILZ-transfected mg) was extracted, run on a gel, and transferred to the filter. The
clone (Figure 3Ac, lane 2) but not in the cytoplasm (Fig- filter was hybridized with labeled GILZ cDNA and exposed for auto-
ure 3Ac, lane 4) or in the nucleus and cytoplasm of radiography for 48 hr.
control clone (Figure 3Ac, lanes 1 and 3, respectively).
Anti-b±tubulin antibody was used to control the possi-
ble nuclei contamination with cytoplasm material. Re- 4) but not in the nuclear extracts (Figure 3Ad, lanes 1
and 2).sults in Figure 3Ad indicate that b-tubulin is present in
the cytoplasm protein extracts of control (Figure 3Ad, We also performed experiments to evaluate whether
GILZ protein (Figure 3Ba) and mRNA (Figure 3Bb) arelane 3) and GILZ-transfected clones (Figure 3Ad, lane
Immunity
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induced by treatment for 3 hr with anti-CD3 MAb or anti-
CD3 plus DEX. Results of a representative Western blot
experiment (Figure 3Ba) show that GILZ protein is not
induced by treatment with anti-CD3 MAb (Figure 3Ba,
lane 2) but is induced by treatment with DEX (Figure
3Ba, lane 3) or anti-CD3 plus DEX (Figure 3Ba, lane 4)
in normal thymocytes. Results of a Northern blot assay
(Figure 3Bb) show that GILZ mRNA is not induced by
treatment with anti-CD3 MAb (Figure 3Bb, lane 2) but
is induced by treatment with DEX (Figure 3Bb, lane 3)
or anti-CD3 plus DEX (Figure 3Bb, lane 4). Similar results
are obtained when spleen and lymph node cells are
used and GILZ expression is evaluated at 3, 10, and 20
hr after treatment (data not shown).
GILZ Expression in Transfected T Cells Confers
Resistance to TCR/CD3-Induced Apoptosis
but Not to Apostosis Induced
by Other Stimuli
To test the possible effects of GILZ expression on
apoptosis, we transfected a hybridoma T cell line, 3DO,
which does not express detectable GILZ and has been
used widely in the investigation of apoptosis induced
by anti-CD3 antibodies (Ayroldi et al. 1995; Vito et al.,
1996), with an expression vector in which the GILZ cDNA
is expressed under the control of the cytomegalovirus
promoter. The apoptosis induced by anti-CD3 MAb in
3DO cells has been shown previously to be depen-
dent from the Fas/FasL system (Ayroldi et al., 1997). We
also transfected the empty vector as a control (pcDNA3
control). After selection with G418 antibiotic, cell clones
were screened for GILZ expression by RNase protec-
tion analysis (Figure 4A). For each transfection, nine
clones were tested and used for functional characteriza-
tion. In addition, six normal untransfected clones (nuc/ Figure 4. GILZ Expression Inhibits TCR/CD3-Activated Apostosis
1±6) were tested as additional controls (Figure 4B). (A) RNase protection analysis of GILZ mRNA expression in trans-
The results showed that all cell clones overexpressing fected clones. (1) Clones transfected with empty pcDNA3 (lanes 1
and 2) or with GILZ cDNA (lanes 3±8); tRNA (lane 9); undigestedGILZ (clones GILZ/1±9) were resistant variably to anti-
probe (lane 10). (2) Undigested probe (lane 1); clones transfectedCD3 MAb±induced apoptosis (apoptosis between 5%
with empty pcDNA3 (lanes 2±4) or with GILZ cDNA (lanes 5±7); tRNAand 10%) when compared to pcDNA3 control clones
(lane 8). Twenty micrograms of RNA was loaded on each lane. The
(clones pcDNA3/1±9, apoptosis between 45% and 60%) protected antisense mRNA fragment in clones transfected with
with P,0.001. Nosignificant differences between pcDNA3 empty pcDNA3 or with GILZ cDNA is of 138 and 244 bp, respectively.
clones and untransfected clones (clones nuc/1±6, apo- (B) Protection of transfected 3DO clones from TCR-induced death.
3DO cells were transfected by electroporation with 15 mg linearizedptosis between 45% and 60%) were detectable (Figure
pcDNA3 or 15 mg linearized pcDNA3 vector expressing the GILZ4B). To exclude a possible effect of a GILZ gene on
cDNA. After 36 hr from transfection, the cells were cultured in me-TCR/CD3 membrane expression, which could by itself
dium containing G418 0.8 mg/gr active form, and 100 ml/ of cell
account for diminished sensitivity to anti-CD3±induced suspension were plated in 96-wells plates (4 for each transfection).
apoptosis, all clones were stained with anti-CD3 MAb For induction of apoptosis, cells werecultured 20hr onplates coated
and analyzed by flow cytometry. No differences in CD3 with anti-CD3 (1 mg/ml). The percentage of cell death was assessed
by measurement of the DNA content of isolated nuclei stained withexpression were detected between transfected and un-
propidium iodide. The data shown are representative of three inde-transfected clones (data not shown).
pendent experiments.It has been shown that T cell apoptosis can be induced
by various stimuli other than triggering of the TCR/CD3
complex, including corticosteroids, radiation, and star- expressed in 3DO cells; Figure 6A and Ayroldi et al.,
1997). These results suggest that GILZ can modulatevation (Wyllie, 1980; Bansal et al., 1991; Lowe et al.,
1993). We performed experiments to test whether GILZ apoptosis induced by triggering of a TCR/CD3 complex
but not by other stimuli.expression inhibits T cell apoptosis induced by other
stimuli. Results obtained with the clones GILZ/1,5,7 and
pcDNA3/4,7,8 (Figure 5) indicate that GILZ overexpres- Expression of Fas and FasL in GILZ-Transfected
T Cellssion does not counteract apoptosis induced by DEX,
various doses of ultraviolet (UV) irradiation, starvation, or It has been suggested that T cell AICD is also dependent
on Fas/FasL interaction (Alderson et al., 1995; Dhein ettriggering by cross-linked anti-Fas MAb (Fas is normally
Dexamethasone and T Cell Apoptosis
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Figure 5. Analysis of Apoptosis Induced by Other Stimuli on
Transfected 3DO Clones
(A) Withdrawn trophic factor. (B) UV irradiation (100 J/m2). (C) DEX
treatment (100 nM). (D) anti-Fas MAb (5 mg/ml). All groups were
treated for 20 hr. Cell death was measured as indicated in Fig-
Figure 6. Fas and FasL Expression on Transfected 3DO Clones
ure 4B.
3DO cells transfected with empty vector or with GILZ pcDNA3 were
triggered with anti-CD3 MAb (1 mg/ml) for 20 hr and then analyzed
by a fluorescence-activated cell sorter.al., 1995; Ju et al., 1995). In particular, we have shown
(A) Fas expression. Results (mean of 3 experiments) are expressed
previously that anti-CD3±induced apoptosis in 3DO cells as values of the histogram median. A PE-hamster IgG (isotype-
is blocked by soluble anti-Fas MAb, whereas cross- matched MAb) was used to calculate the background. The standard
linked anti-Fas MAb induces cell death directly (Ayroldi errors (,10%) are omitted for clarity.
(B) FasL expresssion. Percentage of positive cells is indicated inet al., 1997). We performed experiments to test whether
each histogram.blocking of Fas (using soluble, non±cross-linked anti-
Fas MAb, 1 mg/ml) could also inhibit the anti-CD3±
induced apoptosis in 3DO clones. Results indicate that
of anti-CD3±induced apoptosis is the result of inhibitionblocking of Fas significantly inhibits CD3-induced cell
of Fas and FasL mRNA transcription.death (apoptosis, mean of results obtained with three
We also performed kinetic experiments to evaluate bet-normal clones in a 20 hr assay: 4 6 1 in untreated con-
ter the FasL expression and the induction of apoptosis.trols, 63 6 5 in anti-CD3-treated, and 29 6 6 in clones
Results of a representative experiment indicate thattreated with anti-CD3 plus soluble anti-Fas; P,0.01
while in an empty vector-transfected clone, FasL ex-comparing anti-CD3-treated with anti-CD3- plus anti-
pression was evident 10 hr after anti-CD3 treatment;Fas-treated clones). We performed experiments to as-
when the apoptosis was also detectable, neither FasLsess whether the inhibition of apoptosis in GILZ-trans-
expression nor apoptosis was induced in an anti-CD3±fected cells could be mediated by an effect on Fas/FasL
treated GILZ-transfected clone (Table I). These resultssystem expression. Results show that 20 hr anti-CD3
indicate further that GILZ expression inhibits TCR/CD3-MAb treatment induced augmentation of Fas (Fas is
activated apoptosis and FasL expression.already detectable in untreated 3DO cells; Figure 6A)
and induction of FasL (Figure 6B) expression in clones
transfected by the empty vector (pcDNA3/1,2,3,4,7), but Discussion
it did not augment Fas and FasL expression in clones
overexpressing GILZ (clones GILZ/1,2,3,5,7; Figure 6). We performed studies in the attempt to identify genes
whose transcription is regulated by DEX treatment thatSimilar results were obtained when the expression of
mRNA of Fas (Figure 7A) and FasL (Figure7B) was evalu- could be involved in the modulation of T lymphocyte
apoptosis. The data describe the isolation of a newated. These data indicate that GILZ-mediated inhibition
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residues spanned by 7 aa (at positions 76, 83, 90, and
97) and an asparagine residue (at position 87) within the
leucine zipper domain (Figure 2) are compatible with the
canonical leucine zipper structure of the family. GILZ,
like TSC-22, also contains a PAR (Drolet et al., 1991),
and a noncanonical basic domain (6 basic aa underlined
in Figure 2A) that could be involved in binding to DNA
(Hurst H.C., 1994; Takashi and Schultz, 1996). Moreover,
contrary to other leucine zipper molecules (Hope and
Struhl, 1987; Yamamoto et al., 1988; Nicholas et al.,
1991; Goldstone and Lavin, 1994), both TSC-22 and
GILZ have relatively small dimensions (143 and 137 aa,
respectively) suggesting that these two may represent
a new family of low-molecular-weight leucinezipper pro-
teins.
The GILZ mRNA is clearly detectable by Northern blot-
ting in freshly isolated thymocytes, spleen, and lymph
node cells, and mRNA and protein expression is in-
creased in lymphoid tissues, such as thymocytes,
spleen, and lymph nodes by treatment with DEX (Figures
1 and 3). Although these results may suggest that this
gene is mainly expressed in T lymphocytes, a similar
expression in other tissues (including those in which we
have found low or no mRNA expression, Figure 1) cannot
be excluded based on our present results. For instance,
GILZ gene induction may occur as a result of inflamma-
tory processes and tissue regeneration or in the pres-
ence of tissue-specific signals.
GILZ expression is not induced by treatment with anti-
CD3 MAb. However, the increase in GILZ expression
following DEX/T cell interaction suggests that this gene
may be involved in regulating lymphocyte death. DEX
has been shown previously to antagonize apoptosis in
T lymphocytes, including thymocytes and T cell hybrido-
mas, activated by triggering of the TCR/CD3 complex
(Zacharchuk et al., 1990; Yang et al., 1995a). Moreover,
it has been shown that transgenic expression of anti-
sense RNA to glucocorticoid receptor significantly af-Figure 7. Effect of GILZ on Expression of Fas and FasL mRNA
fects the thymocyte development (King et al., 1995). The(A) Expression of Fas mRNA in transfected clones. Total RNA was
results, obtained by transfection experiments, indicateextracted, separated on agarose gel, and transferred to nitrocellu-
lose filter. The filter was hybridized with nick translation labeled that the GILZ gene is able to inhibit T cell apoptosis
GILZ cDNA probe, washed, and exposed for autoradiography for induced by treatment with anti-CD3 MAb. On the con-
24 hr. Each lane was loaded with 20 mg of total RNA. Clones trary, the same transfected clones are not protected
transfected with empty pcDNA3 untreated (lanes 1, 3, 5, 7, 9) or against the PCD induced with other typical apoptotic
treated with anti-CD3 MAb (1 mg/ml) for 20 hr (lanes 2, 4, 6, 8, 10);
agents, such as DEX, UV irradiation, serum starvation,clones transfected with GILZ cDNA untreated (lanes 11, 13, 15, 17,
or triggering of Fas by cross-linked anti-Fas MAb. These19) or treated with anti-CD3 MAb (1 mg/ml) for 20 hr (lanes 12, 14,
16, 18, 20). data indicate that GILZ is specific in counteracting T
(B) RNase protection analysis of FasL mRNA expression in the cell death activated by triggering of the TCR/CD3 com-
transfected clones. FasL (lane 1) or b-actin (lane 2) undigested plex and suggest that GILZ could contribute in part to
probes; clones transfected with empty pcDNA3 untreated (lanes 3, the DEX-induced inhibition of TCR/CD3-activated apo-
5, 7, 16, 18) or treated with anti-CD3 MAb (1 mg/ml) for 20 hr (lanes
ptosis and to the regulation of T cell development.4, 6, 8, 17, 19); clones transfected with GILZ cDNA untreated (lanes
This protective effect opens the question about the9, 11, 13, 20, 22) or treated with anti-CD3 MAb (1 mg/ml) for 20 hr
possible mechanism(s) of GILZ-induced inhibition of(lanes 10, 12, 14, 21, 23); tRNA (lane 15). 20 mg RNA was loaded on
each lane. The protected antisense mRNA FasL fragment is 184 bp. apoptosis. Our present results indicate that the apo-
ptosis inhibition, associated to GILZ overexpression,
correlates with the inhibition of Fas and FasL up-regula-
member of the leucine zipper family, GILZ, able to inhibit tion induced by treatment with anti-CD3 MAb (Figures
TCR-activated cell death. 6, 7, and 8). These data are in part compatible with
The GILZ putative protein has good homology with previous observations showing that DEX can inhibit
all the other members of this family in the leucine zipper FasL expression thus regulating AICD (Yang et al.,
domain including the TSC-22, whose function has not 1995a, 1995b). One possibility is that GILZ interacts with
been defined and has also been shown to be induced other molecules, at the present unknown, which are
involved in the activation of Fas and FasL genes. GILZby DEX treatment (Shibanuma et al., 1992). Four leucine
Dexamethasone and T Cell Apoptosis
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Table 1. Time Course of FasL Expression Related to Anti-CD3±Induced Apoptosis on an Empty Vector±or GILZ-Transfected Clonea
3 hr 6 hr 10 hr
FasL Apoptosis FasL Apoptosis FasL Apoptosis
pcDNA3 0.7b 1.3 1.0 2.5 5.7 2.9
pcDNA3 1Anti-CD3 1.2 1.7 1.1 3.7 81.1 72.0
GILZ 1.0 0.3 1.7 1.8 0.1 2.8
GILZ 1 Anti-CD3 0.6 0.9 1.2 1.4 1.4 2.7
a An empty vector±transfected clone (pcDNA3, clone 4) and a GILZ-transfected clone (GILZ, clone 7) were used in the experiment.
b Numbers represent the percentage of cells positive for FasL as determined by flow cytometry analysis using anti-FasL mAb or the percentage
apoptosis as determined by flow cytometry analysis of propidium iodide-labeled cells.
Subtraction Probe Procedure and Library Screeningcould interact either with signal(s) induced by TCR/CD3
To construct the subtracted probe, a biotinylated copy of the unin-triggering in activated lymphocyte or directly with tran-
duced pool of mRNA (10 mg) and 32P-labeled cDNA from the inducedscription factors involved in the regulation of Fas and mRNA (1 mg) were coprecipitated in ethanol. The precipitate was
FasL gene transcription acting as a suppressor factor. dried and dissolved in 23 hybridization buffer. Sample was heated
Our results, showing that GILZ is present in the cell at 1008C for 1 min and then incubated at 688C for 24 hr. To separate
unhybridized from hybridized sequences, reaction was diluted 10nucleus and that its overexpression inhibits the Fas and
to 15 times with streptavidin binding buffer and incubated withFasL mRNAs, suggest but do not prove that GILZ medi-
streptavidin for 10 min at room temperature. Two phenol-chloroformates inhibition of apoptosis acting as a transcriptional
extraction were performed. After precipitation, the labeled cDNArepressor. Experiments using inducible transfectants
probe was resuspended in 50 ml of sterile water and used directly
could better address this point and further clarify the as a subtraction probe for screening the cDNA library.
role of GILZ expression in the inhibition of Fas and FasL Nitrocellulose filters (Amersham Life Science International PLC,
Beckinghamshire, England) obtained by blotting plates containingmRNA transcription. Such studies are currently being
5 3 104 clones were hybridized in 53 SSC, 53 Denhardt's solution,pursued in our laboratory.
1% SDS, 100 mg/ml tRNA (Sigma), and 20 mM sodium pyrophos-
phate (pH 6.8) at 428C for 12 hr, and the final wash was in 0.23Experimental Procedures
SSC, 0.1% SDS at 658C for 30 min.
Cells and Culture Conditions
Cells of different organs were obtained from 3- to 5-week-old C3H/ Northern Blot Analysis
HeN mice purchased from Charles River (Milan, Italy). Lymph nodes Indicated amounts (see figure legends) of total cytoplasm of RNA
and splenocytes were passed through a nylon wool column for were separated in 1.2% agarose gels and transferred to nitrocellu-
removal of adherent cells. The cell suspensions were washed, fil- lose filters (Scheicher and Schuell, Dassel, Germany). DNA probes
tered, and adjusted to a concentration of 8 3 106 cells/ml in complete were 32P-labeled using the nick translation kit from Boehringer
medium. The cells were incubated at 378C alone or with 100 nM Mannheim. Hybridization was carried out overnight. Filters were
DEX (Sigma, St. Louis, MO) for different times. washed three times in 0.23 SSC with 0.5% SDS at 378C followed
A subline obtained in our laboratory of the mouse hybridoma by two washes at 658C.
T cell line (3DO) maintained in suspension in RPMI 1640 medium
supplemented with 10% fetal calf serum (FCS) and 10 mM HEPES
Primer-Extension Techniquebuffer was used for transfection experiments.
The primer extension has been performed according to the proce-
dure of Maniatis et al. (1989). The radiolabeled DNA primer (105RNA Preparation
cycles per minute), complementary to sequence from nucleotide atTotal cytoplasm RNA was isolated by using the protocol of Chirgwin
position 298 to nucleotide at position 327 of the GILZ gene, was(1979). Polyadenylated RNA was obtained as described previously
mixed with 20 mg of mRNA from DEX-treated (3 hr) thymocytes.(Maniatis et al., 1989).
Library Construction DNA Sequence Determination
A directionally cloned cDNA library was constructed by using poly- cDNA clones were sequencedusing T7 DNA polymerase (Sequenase
adenylated cytoplasm RNA from thymocytes cultured for 3 hr in the kit, US Biochemical, Cleveland, OH) in conjunction with custom-
presence of DEX, according to the protocol of Maniatis et al. (1989). synthesized 20- and 21-mer oligonucleotide primers (complemen-
First-strand cDNA was obtained with a reverse reaction using an tary to the cDNA sequence) and primers complementary to the
oligo (dT) primer (10 mg) and7 mg of polyadenylated RNA. To monitor plasmid-cloning site sequences. Overlapping sequences were ob-
synthesis, 20 mCi [32P]dCTP (3,000 Ci/mmol) was included in the tained for both strands of the cDNA. cDNA sequences were derived
reaction mixture. Second-strand cDNA was synthesized according from clones isolated from the screening of cDNA library.
to the procedures described by Gubler and Hoffman (1983). The All sequences analyzed and identification of structuralmotifs were
cDNA was blunt-ended by using T4 polymerase (Boehringer done with the Wisconsin Sequence Analysis Package Software Pro-
Mannheim, Mannheim, Germany) and then methylated with EcoRI gram (Genetics Computer Group, University Research Park, Madi-
methylase (Boehringer Mannheim). EcoRI linkers were ligated to son, WI).
cDNA with T4 DNA ligase (New England Biolabs, Beverly, MA) at
168C for 12 hr. Following the ligation of linkers, the reaction was
inactivated warming at 688C for 15 min. The cDNA suspension was In Vitro Translation
RNA was translated in vitro using a rabbit reticulocyte lysate (Pro-precipitated in ethanol and purified on the column of CL4B (In-
vitrogen BV, San Diego, CA). mega Corporation, Madison, WI) by the manufacturer's recom-
mended procedure in the presence of [35S]methionine (Amersham),The cDNA was inserted into lgt11 arms using EcoRI adaptors,
following manufacture's protocol (Invitrogen BV). Recombinants and the products were analyzed with 15% SDS-polyacrylamide gel
electrophoresis. After electrophoresis, the gel was fixed and autora-clones (0.25 3 104 plaque-forming units/ml) were screened by hy-
bridization with the subtraction probe. diographed.
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Preparation of Rabbit Anti-Mouse Antiserum to Fas (hamster anti-mouse, clone Jo2; Pharmingen), then washed
and plated on wells coated with an antibody to hamster IgG (5 mg/and Western Blot Analysis
A rabbit polyclonal antiserum recognizing GILZ was prepared with well; Pharmingen).
the use of a fusion protein containing the full GILZ amino acid
sequence fused to glutathione S-transferase (Pharmacia, Upsala, UV Irradiation, DEX Treatment, and Starvation
Sweden). Glutathione S-transferase fusion protein was expressed In some experiments clones transfected with empty pcDNA3 or
in Escherichia coli, induced with 1 mM isopropyl-b-D-thiogalacto- GILZ-cDNA were exposed to different doses of UV rays from a UV
pyransside and purified with glutathione (GSH)-agarose beads as Stratalinker (model 1800, Stratagene, La Jolla, CA).
described previously (Tan et al., 1994). This preparation was used Aliquots of 2 ml of transfected clones (1 3 106 cells/ml) were
to immunize New Zealand white rabbits (1 mg/rabbit). After 4 weeks incubated with DEX or in deprivation conditions (1% FCS). The
a booster injection of 0.2 mg of protein was given intravenously and apoptosis was evaluated after 20 hr as described below.
blood was collected 1 week later for preparation of antiserum. The
antiserum was purified using fusion protein immobilized on nitrocel- Flow Cytometry Analysis
lulose filter according to Maniatis protocol. The antiserum was used A single suspension (1 3 106 cells/sample) was incubated for 30
for Western blot analysis of proteins extracted from thymocytes min on ice in 50 ml staining buffer (phosphate-buffered saline plus
treated with or without DEX and of proteins extracted from 3DO 5% FCS), containing 10 mg/ml hamster anti-mouse Fas MAb directly
clones, as previously described (Ayroldi et al., 1997). Nuclear pro- conjugated to R-phycoerythrin (PE) or PE-hamster IgG (isotype con-
teins were prepared from isolated nuclei as described previously trol). Both MAbs were purchased from Pharmingen. Cells were also
by others (Marzluff and Huang, 1985), and an anti-b±tubulin MAb stained with rabbit polyclonal antibody raised against a peptide
(Calbiochem, San Diego, CA) was used as control efficacy of nuclei corresponding to amino acids 260±279 mapping at the carboxy
separation. terminus of human FasL (Santa Cruz Biotechnology, Santa Cruz,
CA) or with isotype-matched antibody, and with anti-rabbit IgG con-
Transfections of Cultured Cells jugated with fluorescein, F(ab9)2 fragment (Sigma), as a second-step
The GILZ cDNA coding sequence (874 bp) was cloned into pcDNA3 reagent.
plasmid (Invitrogen) for expression in mammalian cells. 3DO cells All clones were stained with hamster anti-mouse aCD3, directly
were transfected by electroporation (300 mA, 960 mF) with 15 mg conjugated with fluorescein (Pharmingen). The median or percent-
of linearized pcDNA3 vector (control clones) or 15 mg of linearized age of Fas and FasL histograms was calculated using lysis II re-
pcDNA3 vector expressing the GILZ cDNA. Thirty-six hours after search software (Becton-Dickinson, Mountain View, CA).
transfection, the cells were cultured in medium containing G418 0.8
mg/g active form (GIBCO-BRL, Life Technologies, Paisley, Scot-
Apoptosis Evaluation by Propidium Iodide Solution
land), and 100 ml/ml of cell suspension was plated in 96-wells plates
Apoptosis was measured by flow cytometry as described elsewhere
(4 for each transfection). After 15±20 days, no more than 15% of (Nicoletti et al., 1991). Briefly, cells were centrifuged and the pellets
the wells presented live growing cells. These cells were considered resuspended in 1.5 ml hypotonic propidium iodide solution. The
clones and then analyzed in RNAse protection for the expression tubes were kept at 48C in the dark overnight. The propidium iodide-
of exogenous GILZ (Vito et al., 1996; Nocentini et al., 1997).
fluorescence of individual nuclei was measured by flow cytometry
with standard FACScan equipment (Becton Dickinson).
RNase Protection Analysis
GILZ probe for RNase protection analysis was constructed by
Statistical Analysispolymerase chain reaction (PCR) using the forward primer CCATCT
Each experimentwas performedat least three times. RepresentativeGGGTCCACTCCAGT (located on GILZ, 763-782 bp) and the Re-
experiments are shown, unless otherwise indicated in the figureverse primer AGGACAGTGGGAGTGGCACC (located on pcDNA3).
legends. The means 6 SD of three different experiments are insteadFasL probe for RNase protection analysis was constructed by
included in the text. Because of the abnormal distribution of thePCR using the forward primer CACATATGGAACCGCTCTGATC and
data, nonparametric tests (Kruskall-Wallis's analysis of variance)the reverse primer CATTAGCACCAGATCCTCAGGA (located on
were adopted for statistical evaluation.FasL cDNA, 610±631 bp and 722±743, respectively). PCR products
(244 bp for GILZ and 184 for FasL) were cloned into pCRII vector
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